(Q33789911)

29 July 2017

1 reference

title

The AFFIRM trial: main trial and substudies-what can We expect? (English)

1 reference

29 July 2017

Wyse DG

1

1 reference

29 July 2017

language of work or name

1 reference

1 January 2000

1 reference

Journal of Interventional Cardiac Electrophysiology

29 July 2017

published in

1 reference

29 July 2017

volume

4 Suppl 1

1 reference

29 July 2017

page(s)

171-176

1 reference

A prospective hemodynamic evaluation of patients with chronic atrial fibrillation undergoing radiofrequency catheter ablation of the atrioventricular junction

29 July 2017

cites work

1 reference

12 December 2020

Serial antiarrhythmic drug treatment to maintain sinus rhythm after electrical cardioversion for chronic atrial fibrillation or atrial flutter

1 reference

12 December 2020

Prevention of embolic events after cardioversion of atrial fibrillation. Current and evolving strategies

1 reference

12 December 2020

Mortality and morbidity in patients receiving encainide, flecainide, or placebo. The Cardiac Arrhythmia Suppression Trial

1 reference

12 December 2020

The cost-effectiveness of automatic implantable cardiac defibrillators: results from MADIT. Multicenter Automatic Defibrillator Implantation Trial

1 reference

12 December 2020

Comparison of the effects of AV nodal ablation versus AV nodal modification in patients with congestive heart failure and uncontrolled atrial fibrillation.

1 reference

12 December 2020

The Ablate and Pace Trial: a prospective study of catheter ablation of the AV conduction system and permanent pacemaker implantation for treatment of atrial fibrillation. APT Investigators.

1 reference

12 December 2020

Antiarrhythmic drug therapy and cardiac mortality in atrial fibrillation. The Stroke Prevention in Atrial Fibrillation Investigators

1 reference

12 December 2020

Left ventricular dysfunction due to atrial fibrillation in patients initially believed to have idiopathic dilated cardiomyopathy

1 reference

12 December 2020

Comparisons of quality of life and cardiac performance after complete atrioventricular junction ablation and atrioventricular junction modification in patients with medically refractory atrial fibrillation

1 reference

12 December 2020

Efficacy and safety of quinidine therapy for maintenance of sinus rhythm after cardioversion. A meta-analysis of randomized control trials.

1 reference

12 December 2020

Assessment of atrioventricular junction ablation and DDDR mode-switching pacemaker versus pharmacological treatment in patients with severely symptomatic paroxysmal atrial fibrillation: a randomized controlled study.

1 reference

12 December 2020

Asymptomatic arrhythmias in patients with symptomatic paroxysmal atrial fibrillation and paroxysmal supraventricular tachycardia.

1 reference

12 December 2020

Effect of the antiarrhythmic agent moricizine on survival after myocardial infarction

1 reference

12 December 2020

Atrial fibrillation follow-up investigation of rhythm management -- the AFFIRM study design. The Planning and Steering Committees of the AFFIRM study for the NHLBI AFFIRM investigators

1 reference

12 December 2020

Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation. Analysis of pooled data from five randomized controlled trials

1 reference

12 December 2020

Identifiers

DOI

10.1023/A:1009815606734

1 reference

Dimensions Publication ID

29 July 2017

1042051768

0 references

1 reference